| Price | 114.20p on 24-03-2026 at 18:45:10 |
|---|---|
| Change | 0.20p 0.18% |
| Buy | 115.00p |
| Sell | 114.00p |
| Last Trade: | Buy 24,145.00 at 114.20p |
| Day's Volume: | 235,278 |
| Last Close: | 114.20p |
| Open: | 114.00p |
| ISIN: | GB00BY2Z0H74 |
| Day's Range | 112.40p - 115.20p |
| 52wk Range: | 100.40p - 148.00p |
| Market Capitalisation: | £276.15m |
| VWAP: | 113.95245p |
| Shares in Issue: | 241.81m |
PureTech (PRTC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 24,145 | 114.20p | Suspected BUY Trade |
16:35:11 - 24-Mar-26 |
| Buy* | 645 | 114.60p | Automatic Execution |
16:29:39 - 24-Mar-26 |
| Buy* | 52 | 114.60p | Automatic Execution |
16:29:39 - 24-Mar-26 |
| Buy* | 97 | 114.60p | Automatic Execution |
16:29:39 - 24-Mar-26 |
| Buy* | 437 | 114.60p | SI Trade |
16:29:38 - 24-Mar-26 |
| Sell* | 9 | 114.296p | Ordinary |
16:26:06 - 24-Mar-26 |
| Unknown* | 0 | 114.20p | SI Trade |
16:25:40 - 24-Mar-26 |
| Buy* | 479 | 114.80p | Automatic Execution |
16:22:23 - 24-Mar-26 |
| Buy* | 501 | 114.40p | Automatic Execution |
16:22:21 - 24-Mar-26 |
| Buy* | 829 | 114.40p | Automatic Execution |
16:21:52 - 24-Mar-26 |
PureTech (PRTC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Mar 2026 4:35 pm | RNS | PDMR Notification RSU Vesting |
| 2nd Mar 2026 7:00 am | RNS | Total Voting Rights |
| 25th Feb 2026 7:00 am | RNS-R | PRTC to Present at Leerink Healthcare Conference |
| 19th Feb 2026 5:15 pm | RNS-R | PRTC's Deupirfenidone Granted FDA & EU ODD for IPF |
| 6th Jan 2026 12:00 pm | RNS-R | PureTech to Present at the JP Morgan Conference |
| 18th Dec 2025 7:00 am | RNS | PureTech Appoints Robert Lyne as CEO |
| 10th Dec 2025 5:41 pm | RNS | Results of AGM on June 16, 2025 – Update Statement |
| 10th Dec 2025 5:30 pm | RNS | Holding(s) in Company |
| 8th Dec 2025 7:00 am | RNS-R | PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26 |
| 5th Dec 2025 6:00 pm | RNS-R | PRTC's Gallop: Positive Initial Topline AML Data |
